• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old

tetano

Editor, Senior Moderator
BMC Health Serv Res. 2019 Aug 19;19(1):585. doi: 10.1186/s12913-019-4412-7.
[h=1]Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old.[/h] Trucchi C[SUP]1[/SUP], Paganino C[SUP]2[/SUP], Orsi A[SUP]3,[/SUP][SUP]4[/SUP], Amicizia D[SUP]2,[/SUP][SUP]3[/SUP], Tisa V[SUP]3[/SUP], Piazza MF[SUP]2,[/SUP][SUP]3[/SUP], Gallo D[SUP]2[/SUP], Simonetti S[SUP]5[/SUP], Buonopane B[SUP]5[/SUP], Icardi G[SUP]3,[/SUP][SUP]4[/SUP], Ansaldi F[SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h] 1 Azienda Ligure Sanitaria (A.Li.Sa.), Genoa, Italy. cecilia.trucchi@regione.liguria.it. 2 Azienda Ligure Sanitaria (A.Li.Sa.), Genoa, Italy. 3 Department of Health Sciences, University of Genoa, Genoa, Italy. 4 Hygiene Unit, San Martino Polyclinic Hospital, Genoa, Italy. 5 Liguria Digitale S.p.A., Genoa, Italy.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza-like illnesses (ILIs) and lower respiratory tract infections (LRTIs) cause substantial morbidity and mortality worldwide. The study assessed the health and economic burden of ILI and LRTI according to age and comorbidities, since available evidence is limited and heterogeneous.
[h=4]METHOD:[/h] The prevalence of comorbidities, the seasonal incidence rates and the mean and per capita direct costs of ED accesses for ILI/LRTI, whether followed by hospitalization or not, recorded in adults aged ≥50 years over the last 6 years, in the referral hospitals located in the Genoese metropolitan area (Liguria, Italy) where the syndromic surveillance system is active, were evaluated through a retrospective observational study. Comorbidities were estimated through the Chronic Condition Data Warehouse that integrates multiple Medicare data sources. A comparison with the administrative healthcare International Classification of Diseases-9th revision-Clinical Modification (ICD-9-CM)-based data was also conducted.
[h=4]RESULTS:[/h] The prevalence of subjects with ≥1 comorbidity ranged from 23.49 to 59.92%. The most prevalent all-age comorbidities were cardiovascular diseases and cancer. The overall ILI/LRTI incidence rate was 6.73/1000 person-years, almost double the value derived from routine data, and increased with age. The highest rates were observed in patients with renal failure and bronchopneumopathies. The mean cost of ED accesses/hospitalization for ILI/LRTI was ?3353 and was almost twice as high in the ≥85 years as in the youngest age-group. The highest mean costs were observed in patients with renal failure and cancer. The per capita costs increased from ?4 to ?71 with age, and were highest in patients with renal failure and bronchopneumopathy.
[h=4]CONCLUSION:[/h] The burden of ILIs/LRTIs in terms of ED accesses and hospitalizations in adults aged ≥50 years is heavy, and is related to increasing age and, especially, to specific comorbidities. These results could contribute to revising age- and risk-based anti-influenza and -pneumococcus immunization strategies.


[h=4]KEYWORDS:[/h] Anti-influenza and pneumococcus immunization strategies; Chronic condition data warehouse; Comorbidities; Influenza-like illness; Lower respiratory tract infection; Syndromic surveillance system

PMID: 31426795 DOI: 10.1186/s12913-019-4412-7
Free full text
 
Back
Top Bottom